Author: Michelle Valderama

Improving the Management of HIV Disease®: An Advanced CME Live Course in HIV Pathogenesis, Antiretrovirals, and Other Selected Issues in HIV Disease Management–Los Angeles, May 6, 2019

Infectious and Other Complications of Immunobiologic Agents Used by Individuals With HIV Infection Peter Chin-Hong, MD Update From the 2019 Conference on Retroviruses and Opportunistic Infections Constance A. Benson, MD Investigational Approaches to Antiretroviral Therapy Eric S. Daar, MD Interactive ART Case-Based Panel Discussion Rajesh T. Gandhi, MD Sexually Transmitted Infections: Burning Issues Jeffrey D. [...]
Key Slides
DETAIL

Improving the Management of HIV Disease®: An Advanced CME Live Course in HIV Pathogenesis, Antiretrovirals, and Other Selected Issues in HIV Disease Management–Washington, DC, April 29, 2019

Investigational Antiretroviral Strategies and Drugs Roy M. Gulick, MD, MPH Treating and Preventing HIV in 2019: Interactive Cases From the Clinic(ians) Michael S. Saag, MD Immune Reconstitution Inflammatory Syndrome (IRIS) in HIV Infection: Beyond What Meets the Eye Irini Sereti, MD, MHS What’s New in Opportunistic Infection and … Washington, DC Henry A. Masur, MD [...]
Key Slides
DETAIL

Improving the Management of HIV Disease®: An Advanced CME Live Course in HIV Pathogenesis, Antiretrovirals, and Other Selected Issues in HIV Disease Management–Berkeley, California, April 9, 2019

Infectious and Other Complications of Immunobiologic Agents Used by Individuals With HIV Infection Peter Chin-Hong, MD Update From CROI 2019: Ending AIDS by 2030 Robert T. Schooley, MD New Drugs and Novel Strategies for Antiretroviral Therapy Constance A. Benson, MD Interactive ART Cases From the Clinic: Is There One Right Answer? Joseph J. Eron, Jr, [...]
Key Slides
DETAIL

Improving the Management of HIV Disease®: An Advanced CME Live Course in HIV Pathogenesis, Antiretrovirals, and Other Selected Issues in HIV Disease Management–Atlanta, Georgia, March 29, 2019

Infectious and Other Complications of Immunobiologic Agents Used by Individuals With HIV Infection Peter Chin-Hong, MD Update From the 2019 Conference on Retroviruses and Opportunistic Infections Jeffrey L. Lennox, MD New Drugs in Development: Are We Ready for Long-Acting ART? Melanie A. Thompson, MD Interactive ART Cases From the Clinic(ians): Case-Based Panel Discussion Michael S. [...]
Key Slides
DETAIL

Improving the Management of HIV Disease®: An Advanced CME Live Course in HIV Pathogenesis, Antiretrovirals, and Other Selected Issues in HIV Disease Management–New York, New York, March 18, 2019

Therapeutic HIV Vaccines and Broadly Neutralizing Antibodies Magdalena E. Sobieszczyk, MD, MPH Update From the 2019 Conference on Retroviruses and Opportunistic Infections Rajesh T. Gandhi, MD Interactive ART Cases From the Clinic(ians): Case-Based Panel Discussion Michael S. Saag, MD Interactive PrEP Case-Based Panel Discussion Roy M. Gulick, MD, MPH ART in Women and Pregnancy: InSTIs, [...]
Key Slides
DETAIL

2018 CLINICAL CONFERENCE at the National Ryan White Conference on HIV Care & Treatment

National Harbor, Maryland
Sunday, December 9 to Tuesday, December 11, 2018

Podcasts
DETAIL

2018 CLINICAL CONFERENCE at the National Ryan White Conference on HIV Care & Treatment

National Harbor, Maryland
Sunday, December 9 to Tuesday, December 11, 2018

Webcasts
DETAIL

Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2018 Recommendations of the International Antiviral Society–USA Panel

Read the full text article Saag MS, Benson CA, Gandhi RT, et al. Antiretroviral drugs for treatment and prevention of HIV infection in adults: 2018 recommendations of the International Antiviral Society-USA Panel. JAMA. 2018;320(4):379-396 Abstract Importance Antiretroviral therapy (ART) is the cornerstone of prevention and management of HIV infection. Objective To evaluate new data and [...]
Guidelines
DETAIL

test

is the sky blue?Toggle content goes here, click edit button to change this text.
Uncategorized
DETAIL

Human Immunodeficiency Virus Drug Resistance: 2018 Recommendations of the International Antiviral Society–USA Panel

Read the full text article Günthard HF, Calvez V, Paredes R, Pillay D, Shafer RW, Wensing AM, Jacobsen DM, RichmanDD. Human Immunodeficiency Virus Drug Resistance: 2018 Recommendations of the International Antiviral Society–USA Panel. Clin Infec Dis. 2018. Abstract Background Contemporary antiretroviral therapies (ART) and management strategies have diminished both human immunodeficiency virus (HIV) treatment failure [...]
Guidelines
DETAIL